Sun, Feb 1, 2015, 7:10 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

American Capital Agency Corp. Message Board

thom988 58 posts  |  Last Activity: Jan 30, 2015 2:45 PM Member since: Mar 4, 2014
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • thom988 thom988 Jan 30, 2015 2:45 PM Flag

    In a huge pond, there lived many short fish. They were arrogant and never listened to anyone. In this pond, there also lived a kind-hearted crocodile.

    He advised the fish, “It does not pay to be arrogant and overconfident. It could be your downfall.” But the short fish never listened to him. “There is that crocodile, advising us again,” they would say.

    One afternoon, the crocodile was resting beside a stone near the pond, when two fishermen stopped there to drink water.

    The fishermen noticed that the pond had many fish. “Look! This pond is full of fish. Let’s come here tomorrow with our fishing net,” said one of them. “I am surprised we have not seen this place before!” exclaimed the other.

    The crocodile heard all this. When the fishermen left, he slowly slipped into the pond and went straight to the short fish. “You all had better leave this pond before dawn. Early morning those two fishermen are going to come to this pond with their net,” warned the crocodile.

    But the short fish just laughed and said, “There have been many fishermen who have tried to catch us. These two are not going to catch us either. Do not you worry about us, Mr. Crocodile,” they said in a mocking voice.

    The next morning, the fishermen came and threw their net in the pond. The nets were big and strong. Very soon all the short fish were caught. “If only we had listened to Mr. Crocodile. He had only wanted to help. For our arrogance we have to pay with our lives,” said the short fish.

    The fishermen took the foolish short fish to the market and sold them for a good profit.

  • Hope you all have a great weekend. I'm going fishing :)

    Long and patient

    Sentiment: Strong Buy

  • ... even as all the major markets are down. Impressive!

    Long and patient

    Sentiment: Strong Buy

  • seekingalpha.c*m/news/2261016-opko-files-ind-for-study-of-long-acting-clotting-factor?auth_param=musb7:1acng2g:35cdbf2ae8fb689277fafb96f0f660eb&uprof=46&dr=1#email_link

    Sentiment: Strong Buy

  • thom988 thom988 Jan 30, 2015 10:48 AM Flag

    I would not be surprised with what's been happening with the company. All the best Sert!

    Long and patient

    Sentiment: Strong Buy

  • Reply to

    Falling fast now...SELL SELL

    by s.platnum Jan 30, 2015 9:49 AM
    thom988 thom988 Jan 30, 2015 10:03 AM Flag

    Actually Bryan is just telling the truth for once. His net worth is falling fast!

    Sentiment: Strong Buy

  • community.nasdaq.c*m/community-ratings.aspx?stockticker=OPK

    Long and patient.

    Sentiment: Strong Buy

  • Reply to

    Re Burnaka's comments on no PFE takeover

    by miamianne67 Jan 30, 2015 9:18 AM
    thom988 thom988 Jan 30, 2015 9:29 AM Flag

    I agree... and if you've done your due diligence you know that, in spite of all the rhetoric on this board both positive and negative, we have a solid winner in OPKO now and in the years to come. Good luck!

    Long and patient.

    Sentiment: Strong Buy

  • Reply to

    Googled opk Ireland

    by drangles2000 Jan 30, 2015 5:14 AM
    thom988 thom988 Jan 30, 2015 9:08 AM Flag

    Drangles... Looks like the next couple years are going to be very profitable for us and I'm looking forward to a comfortable retirement. Good luck!

    Long and patient.

    Sentiment: Strong Buy

  • thom988 thom988 Jan 30, 2015 8:46 AM Flag

    Hi Bryan...

    As you know, I'm a long-term holder and have been adding to my position since the end of 2012 from 4.40 to 11.50. (in case you don't know what "long-term" means: it means I buy and hold). There's nothing for me to be embarrassed about you see because currently I'm above water on every share I own.

    How about you Bryan? Why don't you tell us where you are with your current short position at 9.00 or 8.00 or whatever your "story" is today?

    LOL... yeah, I didn't think so which is why you and all your other screen names continue to be the board idiot.

    Long and patient.

    Sentiment: Strong Buy

  • thom988 thom988 Jan 29, 2015 4:40 PM Flag

    You are an idiot.... as usual... however, your job waxing my Mercedes is still open.

    Sentiment: Strong Buy

  • MIAMI & NEW YORK--(BUSINESS WIRE)-- OPKO Health, Inc. (NYSE:OPK) and Pfizer Inc. (NYSE: PFE) today announced the closing of their worldwide agreement for the development and commercialization of hGH-CTP, a long-acting human growth hormone. The closing follows termination of the waiting period under the Hart-Scott Rodino Act.

    Sentiment: Strong Buy

  • Reply to

    Frost hasn't bought this week

    by mrmiami1 Jan 28, 2015 1:46 PM
    thom988 thom988 Jan 28, 2015 2:54 PM Flag

    He's probably been holding off ahead of the launch of 4Kscore in Mexico. He'll start again soon.
    Good luck!

    Long and patient

    Sentiment: Strong Buy

  • Reply to

    TODAYS CLOSE

    by matttall52 Jan 27, 2015 9:36 AM
    thom988 thom988 Jan 27, 2015 11:06 AM Flag

    11.57

    Sentiment: Strong Buy

  • Helps descision making in a patient with a rising PSA and negative prior prostate biopsies.

    clinical.opko.c*m/hs-fs/hub/375787/file-1966750124-pdf/documents/4Kscore_Case_Study_2_101714.pdf

    Sentiment: Strong Buy

  • Correctly Identifies a Patient's Risk for High-Grade Prostate Cancer After MRI and PCA3 Indicated Low Risk.

    clinical.opko.c*m/hs-fs/hub/375787/file-1966740109pdf/documents/4Kscore_Case_Study_1_Rv_10.17.14.pdf

    Sentiment: Strong Buy

  • The 4Kscore Test combines four prostate-specific kallikrein assay results with clinical information in an algorithm that calculates the individual patient’s percent risk for aggressive prostate cancer. It is the only test to assess a patient’s risk for aggressive prostate cancer prior to a prostate biopsy, with a 94% rate of accuracy in detecting aggressive cancer. With the 4Kscore Test, Urologists can more confidently choose to place a low-risk patient under active monitoring or perform a biopsy on a high-risk patient based on their clinical evaluation, enhanced by the 4Kscore Test result.

    The 4Kscore Test has undergone extensive clinical development and confirmation. The biomarkers utilized in the 4Kscore Test are based on over a decade of research conducted by scientists at the Memorial Sloan Kettering Cancer Center and leading research centers in Europe, encompassing over 20,000 men in Europe and the United States. The results have recently been replicated in a prospective, blinded clinical study conducted at 26 urology centers across the United States on 1,012 patients.

    The test has been shown to identify the actual risk of aggressive prostate cancer for the individual patient, including high grade prostate cancer pathology and poor prostate cancer clinical outcomes within 20 years, with both high sensitivity and negative predictive value for aggressive prostate cancer.

    "I think the 4Kscore Test is a great tool for helping us... learn how to test smarter, how to screen patients with PSA smarter and more accurately.”
    ----Dr. Peter Scardino

    Long and patient

    Sentiment: Strong Buy

  • opkodd.wordpress.c*m/2015/01/26/synthetic-long-discount-alert-opko-health/

    Long and patient

    Sentiment: Strong Buy

  • thom988 thom988 Jan 26, 2015 4:18 PM Flag

    miamianne67... OPK is a bargain at 15 bucks!

    Sentiment: Strong Buy

  • stafforddaily.c*m/first-call-rating-update-on-opko-health-inc/321268/

    Opko Health Inc. (NYSE:OPK) has received a Strong Buy rating from First Call Corporation, a division of Thomson Reuters. The rating information was disclosed in the equity research recommendation.

    Analysts from various Brokerage Firms have rated the company and commented on its price target. Opko Health Inc. (NYSE:OPK): 4 Analyst have given the stock of Opko Health Inc. (NYSE:OPK) a near short term price target of $11.88. The standard deviation reading, which is a measure by which the stock price is expected to swing away from the mean estimate, is at $1.93. The higher price target estimate is at $15 while the lower price estimates are fixed at $10.

    Opko Health Inc. (NYSE:OPK) ended the day on a positive note gaining 2.17%. The day opened at $10.61 and the stock hit $10.99 on the upper end. However, intraday bearish pressure saw the price plummet to $10.59, at which some value buying and short covering came in. Closing higher after dropping to such lows only strengthens the counter. The stock last traded at $10.84 with 3,348,324 shares having exchanged hands. The 52-week peak value of the shares is $10.62 and the yearly low is $7.32. The company has a market cap of $4,706 million and there are 434,145,000 outstanding shares.

    Opko Health Inc. (NYSE:OPK) has recorded an average daily volume of 2,506,043 shares for the last 20 days. The volume traded during the previous 20 sessions as a percentage of shares outstanding is 0.58%. The latest short ratio is 22.31. A high short ratio points to heavy build up of shorts while a low ratio signifies lesser short positions. Short interest has changed by -4.16% in the past 1 month. The 3-month %change in short interest was measured at -6.38%. Increase in short interests in the 1-month and 3-month period can have bearish implications for the stock. The total monthly shares shorted relative to the total shares outstanding is 0.108.

    Sentiment: Strong Buy

AGNC
21.55+0.03(+0.14%)Jan 30 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.